FDA Drug · D-0172-2025

Dapsone Gel 7.5%, 90 g, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-03. packaged in an Airless pump pack

Class II · Ongoing

Crystallization

Affected lots / codes — check yours against thisLots T400514, Exp Date 02/2026 & T400808, Exp Date 03/2026

Recalling firm: VIONA PHARMACEUTICALS INC, Cranford, NJ
Classification: Class II (temporary or reversible harm possible)
Status: Ongoing
Quantity: 2760 packs
Distribution: US Nationwide
Recall initiated: December 10, 2024
Classified: January 2, 2025
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0172-2025%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →